Join the Contraceptives group to help and get support from people like you.
Contraceptives News
FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive
DUBLIN, July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved ...
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ – Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Nextstellis (3 mg drospirenone [DRSP] and 14.2 mg estetrol...
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch
PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ – The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (...
Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
ATLANTA, Jan. 17, 2018 /PRNewswire/ – Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral ...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
Ask a question
To post your own question to this support group, sign in or create an account.